Status:
COMPLETED
Can High Convection Volumes be Achieved in Each Patient During Online Post-dilution Hemodiafiltration?
Lead Sponsor:
Amsterdam UMC, location VUmc
Collaborating Sponsors:
UMC Utrecht
Julius Center
Conditions:
End-stage Renal Disease
Renal Replacement Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Two recent randomized controlled trials (RCT) on online hemodiafiltration (HDF) did not show a treatment effect on patient survival when compared with low- or high-flux hemodialysis. Interestingly, po...
Detailed Description
Hemodialysis (HD) is the most common used renal replacement therapy worldwide. The main objective is the removal of excess fluid and toxic solutes from the patient. Despite the relative efficiency of ...
Eligibility Criteria
Inclusion
- Patients treated with HD or HDF since \>6 weeks, 3 times a week;
- Patients able to understand the study procedures;
- Patients willing to provide written informed consent.
Exclusion
- Current age \< 18 years;
- Severe incompliance to dialysis procedure and accompanying prescriptions (frequency and duration of dialysis treatment and fluid restriction);
- Life expectancy \< 3 months due to non-renal disease.
Key Trial Info
Start Date :
March 28 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2015
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT01877499
Start Date
March 28 2013
End Date
June 30 2015
Last Update
March 3 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center - Dianet
Amsterdam, Netherlands
2
Diapriva Dialyse Center
Amsterdam, Netherlands
3
VUmc
Amsterdam, Netherlands
4
Catharina Hospital
Eindhoven, Netherlands